This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

EDURANT - Repackaging

Last Updated: 07/07/2026

Summary

  • The company cannot recommend any practices, procedures, or storage conditions that deviate from product labeling. Stability is not guaranteed for rilpivirine when stored outside of its original packaging. Defer to your institutional/local guidelines for guidance on repackaging pharmaceutical products.
  • Store EDURANT tablets in the original bottle in order to protect from light.1
  • Store EDURANT PED tablets for oral suspension in the original package in order to protect from light and moisture.
  • Store EDURANT tablets and EDURANT PED tablets for oral suspension at 20°C-25°C (68°F-77°F), with excursions permitted to 15°C-30°C (59°F-86°F).1

References

1 EDURANT (rilpivirine) [Prescribing Information]. Titusville, NJ: Janssen Products, LP; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/EDURANT-pi.pdf.  

Would you like to clear and leave your conversation? Message history will be lost.